nodes	percent_of_prediction	percent_of_DWPC	metapath
Diltiazem—CYP3A7—Sorafenib—thyroid cancer	0.0961	0.142	CbGbCtD
Diltiazem—CYP3A7-CYP3A51P—Sorafenib—thyroid cancer	0.0961	0.142	CbGbCtD
Diltiazem—CYP3A5—Sorafenib—thyroid cancer	0.0721	0.106	CbGbCtD
Diltiazem—CYP2C8—Sorafenib—thyroid cancer	0.0693	0.102	CbGbCtD
Diltiazem—CYP2C19—Sorafenib—thyroid cancer	0.0581	0.0857	CbGbCtD
Diltiazem—CYP2C9—Sorafenib—thyroid cancer	0.0483	0.0713	CbGbCtD
Diltiazem—ABCB1—Sorafenib—thyroid cancer	0.0469	0.0692	CbGbCtD
Diltiazem—CYP3A4—Vandetanib—thyroid cancer	0.0466	0.0688	CbGbCtD
Diltiazem—CYP2D6—Sorafenib—thyroid cancer	0.0442	0.0652	CbGbCtD
Diltiazem—ABCB1—Doxorubicin—thyroid cancer	0.0285	0.042	CbGbCtD
Diltiazem—CYP3A4—Sorafenib—thyroid cancer	0.0281	0.0414	CbGbCtD
Diltiazem—CYP2D6—Doxorubicin—thyroid cancer	0.0268	0.0395	CbGbCtD
Diltiazem—CYP3A4—Doxorubicin—thyroid cancer	0.017	0.0251	CbGbCtD
Diltiazem—CACNG1—Arrhythmogenic Right Ventricular Cardiomyopathy—TCF7L1—thyroid cancer	0.00231	0.124	CbGpPWpGaD
Diltiazem—CACNG1—Arrhythmogenic Right Ventricular Cardiomyopathy—LAMA2—thyroid cancer	0.00204	0.109	CbGpPWpGaD
Diltiazem—CACNA1S—Arrhythmogenic Right Ventricular Cardiomyopathy—TCF7L1—thyroid cancer	0.000755	0.0404	CbGpPWpGaD
Diltiazem—CACNA1S—Arrhythmogenic Right Ventricular Cardiomyopathy—LAMA2—thyroid cancer	0.000667	0.0357	CbGpPWpGaD
Diltiazem—Cystitis—Doxorubicin—thyroid cancer	0.00064	0.00211	CcSEcCtD
Diltiazem—Colitis—Doxorubicin—thyroid cancer	0.000636	0.0021	CcSEcCtD
Diltiazem—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00063	0.00208	CcSEcCtD
Diltiazem—Hypertonia—Epirubicin—thyroid cancer	0.000628	0.00207	CcSEcCtD
Diltiazem—Vaginal infection—Doxorubicin—thyroid cancer	0.000626	0.00206	CcSEcCtD
Diltiazem—Abnormal vision—Epirubicin—thyroid cancer	0.000625	0.00206	CcSEcCtD
Diltiazem—Neuropathy—Doxorubicin—thyroid cancer	0.000622	0.00205	CcSEcCtD
Diltiazem—Mental disability—Epirubicin—thyroid cancer	0.000622	0.00205	CcSEcCtD
Diltiazem—Dyspnoea—Sorafenib—thyroid cancer	0.000616	0.00203	CcSEcCtD
Diltiazem—Lymphadenopathy—Epirubicin—thyroid cancer	0.000609	0.00201	CcSEcCtD
Diltiazem—Nausea—Vandetanib—thyroid cancer	0.000609	0.00201	CcSEcCtD
Diltiazem—Dyspepsia—Sorafenib—thyroid cancer	0.000609	0.00201	CcSEcCtD
Diltiazem—Phlebitis—Epirubicin—thyroid cancer	0.000604	0.00199	CcSEcCtD
Diltiazem—Decreased appetite—Sorafenib—thyroid cancer	0.000601	0.00198	CcSEcCtD
Diltiazem—Ecchymosis—Doxorubicin—thyroid cancer	0.000599	0.00197	CcSEcCtD
Diltiazem—Bladder pain—Doxorubicin—thyroid cancer	0.000599	0.00197	CcSEcCtD
Diltiazem—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000597	0.00197	CcSEcCtD
Diltiazem—Fatigue—Sorafenib—thyroid cancer	0.000596	0.00196	CcSEcCtD
Diltiazem—Photosensitivity—Epirubicin—thyroid cancer	0.000592	0.00195	CcSEcCtD
Diltiazem—Constipation—Sorafenib—thyroid cancer	0.000591	0.00195	CcSEcCtD
Diltiazem—Pain—Sorafenib—thyroid cancer	0.000591	0.00195	CcSEcCtD
Diltiazem—Vascular purpura—Epirubicin—thyroid cancer	0.000581	0.00192	CcSEcCtD
Diltiazem—Hypertonia—Doxorubicin—thyroid cancer	0.000581	0.00191	CcSEcCtD
Diltiazem—Abnormal vision—Doxorubicin—thyroid cancer	0.000578	0.00191	CcSEcCtD
Diltiazem—Mental disability—Doxorubicin—thyroid cancer	0.000575	0.0019	CcSEcCtD
Diltiazem—Cardiac failure congestive—Epirubicin—thyroid cancer	0.000573	0.00189	CcSEcCtD
Diltiazem—Lymphadenopathy—Doxorubicin—thyroid cancer	0.000564	0.00186	CcSEcCtD
Diltiazem—Phlebitis—Doxorubicin—thyroid cancer	0.000558	0.00184	CcSEcCtD
Diltiazem—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.000551	0.00182	CcSEcCtD
Diltiazem—Urticaria—Sorafenib—thyroid cancer	0.000549	0.00181	CcSEcCtD
Diltiazem—Photosensitivity—Doxorubicin—thyroid cancer	0.000548	0.00181	CcSEcCtD
Diltiazem—Abdominal pain—Sorafenib—thyroid cancer	0.000547	0.0018	CcSEcCtD
Diltiazem—Body temperature increased—Sorafenib—thyroid cancer	0.000547	0.0018	CcSEcCtD
Diltiazem—Purpura—Epirubicin—thyroid cancer	0.000539	0.00178	CcSEcCtD
Diltiazem—CACNA1C—Arrhythmogenic Right Ventricular Cardiomyopathy—TCF7L1—thyroid cancer	0.000538	0.0288	CbGpPWpGaD
Diltiazem—Vascular purpura—Doxorubicin—thyroid cancer	0.000538	0.00177	CcSEcCtD
Diltiazem—Lethargy—Epirubicin—thyroid cancer	0.000531	0.00175	CcSEcCtD
Diltiazem—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.00053	0.00175	CcSEcCtD
Diltiazem—Osteoarthritis—Epirubicin—thyroid cancer	0.00052	0.00171	CcSEcCtD
Diltiazem—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.00052	0.00171	CcSEcCtD
Diltiazem—Diplopia—Epirubicin—thyroid cancer	0.00052	0.00171	CcSEcCtD
Diltiazem—Affect lability—Epirubicin—thyroid cancer	0.000512	0.00169	CcSEcCtD
Diltiazem—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.00051	0.00168	CcSEcCtD
Diltiazem—Hypersensitivity—Sorafenib—thyroid cancer	0.000509	0.00168	CcSEcCtD
Diltiazem—Face oedema—Epirubicin—thyroid cancer	0.000502	0.00165	CcSEcCtD
Diltiazem—Purpura—Doxorubicin—thyroid cancer	0.000499	0.00165	CcSEcCtD
Diltiazem—Asthenia—Sorafenib—thyroid cancer	0.000496	0.00164	CcSEcCtD
Diltiazem—Cardiac arrest—Epirubicin—thyroid cancer	0.000494	0.00163	CcSEcCtD
Diltiazem—Mood swings—Epirubicin—thyroid cancer	0.000493	0.00162	CcSEcCtD
Diltiazem—Lethargy—Doxorubicin—thyroid cancer	0.000491	0.00162	CcSEcCtD
Diltiazem—Pruritus—Sorafenib—thyroid cancer	0.000489	0.00161	CcSEcCtD
Diltiazem—Osteoarthritis—Doxorubicin—thyroid cancer	0.000481	0.00159	CcSEcCtD
Diltiazem—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.000481	0.00159	CcSEcCtD
Diltiazem—Diplopia—Doxorubicin—thyroid cancer	0.000481	0.00159	CcSEcCtD
Diltiazem—CACNA1C—Arrhythmogenic Right Ventricular Cardiomyopathy—LAMA2—thyroid cancer	0.000476	0.0255	CbGpPWpGaD
Diltiazem—Abdominal pain upper—Epirubicin—thyroid cancer	0.000475	0.00157	CcSEcCtD
Diltiazem—Orthostatic hypotension—Epirubicin—thyroid cancer	0.000475	0.00157	CcSEcCtD
Diltiazem—Affect lability—Doxorubicin—thyroid cancer	0.000474	0.00156	CcSEcCtD
Diltiazem—Diarrhoea—Sorafenib—thyroid cancer	0.000473	0.00156	CcSEcCtD
Diltiazem—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.000468	0.00154	CcSEcCtD
Diltiazem—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.000468	0.00154	CcSEcCtD
Diltiazem—Nasopharyngitis—Epirubicin—thyroid cancer	0.000465	0.00153	CcSEcCtD
Diltiazem—Face oedema—Doxorubicin—thyroid cancer	0.000464	0.00153	CcSEcCtD
Diltiazem—Cardiac arrest—Doxorubicin—thyroid cancer	0.000457	0.00151	CcSEcCtD
Diltiazem—Dizziness—Sorafenib—thyroid cancer	0.000457	0.00151	CcSEcCtD
Diltiazem—Mood swings—Doxorubicin—thyroid cancer	0.000456	0.0015	CcSEcCtD
Diltiazem—Abdominal distension—Epirubicin—thyroid cancer	0.000452	0.00149	CcSEcCtD
Diltiazem—Influenza—Epirubicin—thyroid cancer	0.000449	0.00148	CcSEcCtD
Diltiazem—Vomiting—Sorafenib—thyroid cancer	0.00044	0.00145	CcSEcCtD
Diltiazem—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000439	0.00145	CcSEcCtD
Diltiazem—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000439	0.00145	CcSEcCtD
Diltiazem—Rash—Sorafenib—thyroid cancer	0.000436	0.00144	CcSEcCtD
Diltiazem—Dermatitis—Sorafenib—thyroid cancer	0.000436	0.00144	CcSEcCtD
Diltiazem—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000433	0.00143	CcSEcCtD
Diltiazem—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000433	0.00143	CcSEcCtD
Diltiazem—Headache—Sorafenib—thyroid cancer	0.000433	0.00143	CcSEcCtD
Diltiazem—Bronchitis—Epirubicin—thyroid cancer	0.000432	0.00142	CcSEcCtD
Diltiazem—Nasopharyngitis—Doxorubicin—thyroid cancer	0.00043	0.00142	CcSEcCtD
Diltiazem—Abdominal distension—Doxorubicin—thyroid cancer	0.000419	0.00138	CcSEcCtD
Diltiazem—Influenza—Doxorubicin—thyroid cancer	0.000416	0.00137	CcSEcCtD
Diltiazem—Pollakiuria—Epirubicin—thyroid cancer	0.000415	0.00137	CcSEcCtD
Diltiazem—Nausea—Sorafenib—thyroid cancer	0.000411	0.00135	CcSEcCtD
Diltiazem—Photosensitivity reaction—Epirubicin—thyroid cancer	0.00041	0.00135	CcSEcCtD
Diltiazem—Weight increased—Epirubicin—thyroid cancer	0.000409	0.00135	CcSEcCtD
Diltiazem—Hyperglycaemia—Epirubicin—thyroid cancer	0.000405	0.00134	CcSEcCtD
Diltiazem—CACNA1S—NCAM signaling for neurite out-growth—CDK1—thyroid cancer	0.000401	0.0214	CbGpPWpGaD
Diltiazem—Bronchitis—Doxorubicin—thyroid cancer	0.0004	0.00132	CcSEcCtD
Diltiazem—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000397	0.00131	CcSEcCtD
Diltiazem—Renal failure—Epirubicin—thyroid cancer	0.000394	0.0013	CcSEcCtD
Diltiazem—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000393	0.00129	CcSEcCtD
Diltiazem—Urinary tract infection—Epirubicin—thyroid cancer	0.000389	0.00128	CcSEcCtD
Diltiazem—Conjunctivitis—Epirubicin—thyroid cancer	0.000389	0.00128	CcSEcCtD
Diltiazem—Sweating—Epirubicin—thyroid cancer	0.000384	0.00127	CcSEcCtD
Diltiazem—Pollakiuria—Doxorubicin—thyroid cancer	0.000384	0.00127	CcSEcCtD
Diltiazem—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.00038	0.00125	CcSEcCtD
Diltiazem—Weight increased—Doxorubicin—thyroid cancer	0.000378	0.00125	CcSEcCtD
Diltiazem—Epistaxis—Epirubicin—thyroid cancer	0.000378	0.00125	CcSEcCtD
Diltiazem—Sinusitis—Epirubicin—thyroid cancer	0.000376	0.00124	CcSEcCtD
Diltiazem—CACNA1C—Regulation of insulin secretion—PRKAR1A—thyroid cancer	0.000376	0.0201	CbGpPWpGaD
Diltiazem—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000375	0.00124	CcSEcCtD
Diltiazem—Agranulocytosis—Epirubicin—thyroid cancer	0.000374	0.00123	CcSEcCtD
Diltiazem—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000368	0.00121	CcSEcCtD
Diltiazem—Bradycardia—Epirubicin—thyroid cancer	0.000366	0.00121	CcSEcCtD
Diltiazem—Renal failure—Doxorubicin—thyroid cancer	0.000364	0.0012	CcSEcCtD
Diltiazem—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000363	0.0012	CcSEcCtD
Diltiazem—Rhinitis—Epirubicin—thyroid cancer	0.000361	0.00119	CcSEcCtD
Diltiazem—Urinary tract infection—Doxorubicin—thyroid cancer	0.00036	0.00119	CcSEcCtD
Diltiazem—Conjunctivitis—Doxorubicin—thyroid cancer	0.00036	0.00119	CcSEcCtD
Diltiazem—CYP2C8—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00036	0.0193	CbGpPWpGaD
Diltiazem—Hepatitis—Epirubicin—thyroid cancer	0.00036	0.00119	CcSEcCtD
Diltiazem—Pharyngitis—Epirubicin—thyroid cancer	0.000357	0.00118	CcSEcCtD
Diltiazem—Sweating—Doxorubicin—thyroid cancer	0.000355	0.00117	CcSEcCtD
Diltiazem—Urinary tract disorder—Epirubicin—thyroid cancer	0.000355	0.00117	CcSEcCtD
Diltiazem—Oedema peripheral—Epirubicin—thyroid cancer	0.000354	0.00117	CcSEcCtD
Diltiazem—Urethral disorder—Epirubicin—thyroid cancer	0.000353	0.00116	CcSEcCtD
Diltiazem—Epistaxis—Doxorubicin—thyroid cancer	0.00035	0.00115	CcSEcCtD
Diltiazem—Sinusitis—Doxorubicin—thyroid cancer	0.000348	0.00115	CcSEcCtD
Diltiazem—Visual impairment—Epirubicin—thyroid cancer	0.000347	0.00114	CcSEcCtD
Diltiazem—Agranulocytosis—Doxorubicin—thyroid cancer	0.000346	0.00114	CcSEcCtD
Diltiazem—Erythema multiforme—Epirubicin—thyroid cancer	0.00034	0.00112	CcSEcCtD
Diltiazem—Bradycardia—Doxorubicin—thyroid cancer	0.000339	0.00112	CcSEcCtD
Diltiazem—Eye disorder—Epirubicin—thyroid cancer	0.000336	0.00111	CcSEcCtD
Diltiazem—Tinnitus—Epirubicin—thyroid cancer	0.000335	0.00111	CcSEcCtD
Diltiazem—Flushing—Epirubicin—thyroid cancer	0.000334	0.0011	CcSEcCtD
Diltiazem—Cardiac disorder—Epirubicin—thyroid cancer	0.000334	0.0011	CcSEcCtD
Diltiazem—Rhinitis—Doxorubicin—thyroid cancer	0.000334	0.0011	CcSEcCtD
Diltiazem—Hepatitis—Doxorubicin—thyroid cancer	0.000333	0.0011	CcSEcCtD
Diltiazem—Pharyngitis—Doxorubicin—thyroid cancer	0.00033	0.00109	CcSEcCtD
Diltiazem—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000329	0.00108	CcSEcCtD
Diltiazem—Oedema peripheral—Doxorubicin—thyroid cancer	0.000328	0.00108	CcSEcCtD
Diltiazem—Angiopathy—Epirubicin—thyroid cancer	0.000326	0.00108	CcSEcCtD
Diltiazem—Urethral disorder—Doxorubicin—thyroid cancer	0.000326	0.00108	CcSEcCtD
Diltiazem—Mediastinal disorder—Epirubicin—thyroid cancer	0.000324	0.00107	CcSEcCtD
Diltiazem—CYP2C19—Arachidonic acid metabolism—HPGD—thyroid cancer	0.000321	0.0172	CbGpPWpGaD
Diltiazem—Arrhythmia—Epirubicin—thyroid cancer	0.000321	0.00106	CcSEcCtD
Diltiazem—Visual impairment—Doxorubicin—thyroid cancer	0.000321	0.00106	CcSEcCtD
Diltiazem—Alopecia—Epirubicin—thyroid cancer	0.000318	0.00105	CcSEcCtD
Diltiazem—Erythema multiforme—Doxorubicin—thyroid cancer	0.000315	0.00104	CcSEcCtD
Diltiazem—Malnutrition—Epirubicin—thyroid cancer	0.000313	0.00103	CcSEcCtD
Diltiazem—Erythema—Epirubicin—thyroid cancer	0.000313	0.00103	CcSEcCtD
Diltiazem—Eye disorder—Doxorubicin—thyroid cancer	0.000311	0.00103	CcSEcCtD
Diltiazem—CACNA1S—Calcium Regulation in the Cardiac Cell—PRKAR1A—thyroid cancer	0.000311	0.0166	CbGpPWpGaD
Diltiazem—Tinnitus—Doxorubicin—thyroid cancer	0.00031	0.00102	CcSEcCtD
Diltiazem—Cardiac disorder—Doxorubicin—thyroid cancer	0.000309	0.00102	CcSEcCtD
Diltiazem—Flushing—Doxorubicin—thyroid cancer	0.000309	0.00102	CcSEcCtD
Diltiazem—Flatulence—Epirubicin—thyroid cancer	0.000309	0.00102	CcSEcCtD
Diltiazem—Tension—Epirubicin—thyroid cancer	0.000307	0.00101	CcSEcCtD
Diltiazem—Dysgeusia—Epirubicin—thyroid cancer	0.000307	0.00101	CcSEcCtD
Diltiazem—Nervousness—Epirubicin—thyroid cancer	0.000304	0.001	CcSEcCtD
Diltiazem—Angiopathy—Doxorubicin—thyroid cancer	0.000302	0.000995	CcSEcCtD
Diltiazem—Muscle spasms—Epirubicin—thyroid cancer	0.000301	0.000992	CcSEcCtD
Diltiazem—Mediastinal disorder—Doxorubicin—thyroid cancer	0.0003	0.000989	CcSEcCtD
Diltiazem—Arrhythmia—Doxorubicin—thyroid cancer	0.000297	0.00098	CcSEcCtD
Diltiazem—CACNA1C—Integration of energy metabolism—PRKAR1A—thyroid cancer	0.000295	0.0158	CbGpPWpGaD
Diltiazem—Vision blurred—Epirubicin—thyroid cancer	0.000295	0.000973	CcSEcCtD
Diltiazem—Alopecia—Doxorubicin—thyroid cancer	0.000294	0.000969	CcSEcCtD
Diltiazem—CYP2C9—Arachidonic acid metabolism—HPGD—thyroid cancer	0.000293	0.0157	CbGpPWpGaD
Diltiazem—Ill-defined disorder—Epirubicin—thyroid cancer	0.000291	0.000958	CcSEcCtD
Diltiazem—Malnutrition—Doxorubicin—thyroid cancer	0.00029	0.000955	CcSEcCtD
Diltiazem—Erythema—Doxorubicin—thyroid cancer	0.00029	0.000955	CcSEcCtD
Diltiazem—CACNA1C—NCAM signaling for neurite out-growth—CDK1—thyroid cancer	0.000286	0.0153	CbGpPWpGaD
Diltiazem—Flatulence—Doxorubicin—thyroid cancer	0.000285	0.000941	CcSEcCtD
Diltiazem—Tension—Doxorubicin—thyroid cancer	0.000284	0.000937	CcSEcCtD
Diltiazem—Dysgeusia—Doxorubicin—thyroid cancer	0.000284	0.000935	CcSEcCtD
Diltiazem—Malaise—Epirubicin—thyroid cancer	0.000282	0.000931	CcSEcCtD
Diltiazem—Nervousness—Doxorubicin—thyroid cancer	0.000281	0.000927	CcSEcCtD
Diltiazem—Vertigo—Epirubicin—thyroid cancer	0.000281	0.000927	CcSEcCtD
Diltiazem—Syncope—Epirubicin—thyroid cancer	0.000281	0.000925	CcSEcCtD
Diltiazem—Leukopenia—Epirubicin—thyroid cancer	0.00028	0.000924	CcSEcCtD
Diltiazem—Muscle spasms—Doxorubicin—thyroid cancer	0.000279	0.000918	CcSEcCtD
Diltiazem—Palpitations—Epirubicin—thyroid cancer	0.000277	0.000912	CcSEcCtD
Diltiazem—Loss of consciousness—Epirubicin—thyroid cancer	0.000275	0.000907	CcSEcCtD
Diltiazem—Cough—Epirubicin—thyroid cancer	0.000273	0.000901	CcSEcCtD
Diltiazem—Vision blurred—Doxorubicin—thyroid cancer	0.000273	0.0009	CcSEcCtD
Diltiazem—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000269	0.000886	CcSEcCtD
Diltiazem—Arthralgia—Epirubicin—thyroid cancer	0.000267	0.000879	CcSEcCtD
Diltiazem—Chest pain—Epirubicin—thyroid cancer	0.000267	0.000879	CcSEcCtD
Diltiazem—Myalgia—Epirubicin—thyroid cancer	0.000267	0.000879	CcSEcCtD
Diltiazem—Discomfort—Epirubicin—thyroid cancer	0.000263	0.000868	CcSEcCtD
Diltiazem—CYP3A7—Metapathway biotransformation—CHST14—thyroid cancer	0.000262	0.014	CbGpPWpGaD
Diltiazem—Malaise—Doxorubicin—thyroid cancer	0.000261	0.000861	CcSEcCtD
Diltiazem—Dry mouth—Epirubicin—thyroid cancer	0.000261	0.000859	CcSEcCtD
Diltiazem—Vertigo—Doxorubicin—thyroid cancer	0.00026	0.000858	CcSEcCtD
Diltiazem—Syncope—Doxorubicin—thyroid cancer	0.00026	0.000856	CcSEcCtD
Diltiazem—Leukopenia—Doxorubicin—thyroid cancer	0.000259	0.000855	CcSEcCtD
Diltiazem—Palpitations—Doxorubicin—thyroid cancer	0.000256	0.000844	CcSEcCtD
Diltiazem—Oedema—Epirubicin—thyroid cancer	0.000256	0.000842	CcSEcCtD
Diltiazem—Loss of consciousness—Doxorubicin—thyroid cancer	0.000255	0.000839	CcSEcCtD
Diltiazem—Infection—Epirubicin—thyroid cancer	0.000254	0.000837	CcSEcCtD
Diltiazem—CYP3A4—Liver X Receptor Pathway—RXRA—thyroid cancer	0.000253	0.0135	CbGpPWpGaD
Diltiazem—Cough—Doxorubicin—thyroid cancer	0.000253	0.000833	CcSEcCtD
Diltiazem—Shock—Epirubicin—thyroid cancer	0.000251	0.000829	CcSEcCtD
Diltiazem—Nervous system disorder—Epirubicin—thyroid cancer	0.000251	0.000826	CcSEcCtD
Diltiazem—Thrombocytopenia—Epirubicin—thyroid cancer	0.00025	0.000825	CcSEcCtD
Diltiazem—Tachycardia—Epirubicin—thyroid cancer	0.000249	0.000822	CcSEcCtD
Diltiazem—Hyperhidrosis—Epirubicin—thyroid cancer	0.000247	0.000814	CcSEcCtD
Diltiazem—Chest pain—Doxorubicin—thyroid cancer	0.000247	0.000813	CcSEcCtD
Diltiazem—Myalgia—Doxorubicin—thyroid cancer	0.000247	0.000813	CcSEcCtD
Diltiazem—Arthralgia—Doxorubicin—thyroid cancer	0.000247	0.000813	CcSEcCtD
Diltiazem—Discomfort—Doxorubicin—thyroid cancer	0.000244	0.000803	CcSEcCtD
Diltiazem—Anorexia—Epirubicin—thyroid cancer	0.000244	0.000803	CcSEcCtD
Diltiazem—Dry mouth—Doxorubicin—thyroid cancer	0.000241	0.000795	CcSEcCtD
Diltiazem—Hypotension—Epirubicin—thyroid cancer	0.000239	0.000787	CcSEcCtD
Diltiazem—Oedema—Doxorubicin—thyroid cancer	0.000236	0.000779	CcSEcCtD
Diltiazem—Infection—Doxorubicin—thyroid cancer	0.000235	0.000774	CcSEcCtD
Diltiazem—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000233	0.000767	CcSEcCtD
Diltiazem—Shock—Doxorubicin—thyroid cancer	0.000233	0.000767	CcSEcCtD
Diltiazem—Nervous system disorder—Doxorubicin—thyroid cancer	0.000232	0.000764	CcSEcCtD
Diltiazem—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000232	0.000763	CcSEcCtD
Diltiazem—Insomnia—Epirubicin—thyroid cancer	0.000231	0.000762	CcSEcCtD
Diltiazem—Tachycardia—Doxorubicin—thyroid cancer	0.000231	0.000761	CcSEcCtD
Diltiazem—Paraesthesia—Epirubicin—thyroid cancer	0.000229	0.000756	CcSEcCtD
Diltiazem—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000229	0.000753	CcSEcCtD
Diltiazem—Dyspnoea—Epirubicin—thyroid cancer	0.000228	0.000751	CcSEcCtD
Diltiazem—Somnolence—Epirubicin—thyroid cancer	0.000227	0.000749	CcSEcCtD
Diltiazem—Anorexia—Doxorubicin—thyroid cancer	0.000225	0.000743	CcSEcCtD
Diltiazem—Dyspepsia—Epirubicin—thyroid cancer	0.000225	0.000741	CcSEcCtD
Diltiazem—Decreased appetite—Epirubicin—thyroid cancer	0.000222	0.000732	CcSEcCtD
Diltiazem—CACNA1C—Calcium Regulation in the Cardiac Cell—PRKAR1A—thyroid cancer	0.000222	0.0119	CbGpPWpGaD
Diltiazem—Hypotension—Doxorubicin—thyroid cancer	0.000221	0.000728	CcSEcCtD
Diltiazem—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000221	0.000727	CcSEcCtD
Diltiazem—Fatigue—Epirubicin—thyroid cancer	0.00022	0.000726	CcSEcCtD
Diltiazem—Pain—Epirubicin—thyroid cancer	0.000219	0.00072	CcSEcCtD
Diltiazem—Constipation—Epirubicin—thyroid cancer	0.000219	0.00072	CcSEcCtD
Diltiazem—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000215	0.00071	CcSEcCtD
Diltiazem—CYP3A5—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000215	0.0115	CbGpPWpGaD
Diltiazem—Insomnia—Doxorubicin—thyroid cancer	0.000214	0.000705	CcSEcCtD
Diltiazem—Paraesthesia—Doxorubicin—thyroid cancer	0.000212	0.0007	CcSEcCtD
Diltiazem—Dyspnoea—Doxorubicin—thyroid cancer	0.000211	0.000695	CcSEcCtD
Diltiazem—Feeling abnormal—Epirubicin—thyroid cancer	0.000211	0.000694	CcSEcCtD
Diltiazem—Somnolence—Doxorubicin—thyroid cancer	0.00021	0.000693	CcSEcCtD
Diltiazem—Dyspepsia—Doxorubicin—thyroid cancer	0.000208	0.000686	CcSEcCtD
Diltiazem—Decreased appetite—Doxorubicin—thyroid cancer	0.000206	0.000677	CcSEcCtD
Diltiazem—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000204	0.000673	CcSEcCtD
Diltiazem—Fatigue—Doxorubicin—thyroid cancer	0.000204	0.000672	CcSEcCtD
Diltiazem—Urticaria—Epirubicin—thyroid cancer	0.000203	0.000669	CcSEcCtD
Diltiazem—Pain—Doxorubicin—thyroid cancer	0.000202	0.000666	CcSEcCtD
Diltiazem—Constipation—Doxorubicin—thyroid cancer	0.000202	0.000666	CcSEcCtD
Diltiazem—Body temperature increased—Epirubicin—thyroid cancer	0.000202	0.000666	CcSEcCtD
Diltiazem—Abdominal pain—Epirubicin—thyroid cancer	0.000202	0.000666	CcSEcCtD
Diltiazem—Feeling abnormal—Doxorubicin—thyroid cancer	0.000195	0.000642	CcSEcCtD
Diltiazem—CYP3A5—Metapathway biotransformation—CHST14—thyroid cancer	0.000189	0.0101	CbGpPWpGaD
Diltiazem—Hypersensitivity—Epirubicin—thyroid cancer	0.000188	0.000621	CcSEcCtD
Diltiazem—Urticaria—Doxorubicin—thyroid cancer	0.000188	0.000619	CcSEcCtD
Diltiazem—Abdominal pain—Doxorubicin—thyroid cancer	0.000187	0.000616	CcSEcCtD
Diltiazem—Body temperature increased—Doxorubicin—thyroid cancer	0.000187	0.000616	CcSEcCtD
Diltiazem—Asthenia—Epirubicin—thyroid cancer	0.000183	0.000604	CcSEcCtD
Diltiazem—Pruritus—Epirubicin—thyroid cancer	0.000181	0.000596	CcSEcCtD
Diltiazem—CYP3A7—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.00018	0.00961	CbGpPWpGaD
Diltiazem—Diarrhoea—Epirubicin—thyroid cancer	0.000175	0.000576	CcSEcCtD
Diltiazem—Hypersensitivity—Doxorubicin—thyroid cancer	0.000174	0.000574	CcSEcCtD
Diltiazem—Asthenia—Doxorubicin—thyroid cancer	0.00017	0.000559	CcSEcCtD
Diltiazem—Dizziness—Epirubicin—thyroid cancer	0.000169	0.000557	CcSEcCtD
Diltiazem—Pruritus—Doxorubicin—thyroid cancer	0.000167	0.000551	CcSEcCtD
Diltiazem—CYP2C19—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000166	0.00888	CbGpPWpGaD
Diltiazem—CYP2C8—Metapathway biotransformation—CHST14—thyroid cancer	0.000164	0.00878	CbGpPWpGaD
Diltiazem—Vomiting—Epirubicin—thyroid cancer	0.000162	0.000536	CcSEcCtD
Diltiazem—ABCB1—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000162	0.00867	CbGpPWpGaD
Diltiazem—Diarrhoea—Doxorubicin—thyroid cancer	0.000162	0.000533	CcSEcCtD
Diltiazem—Rash—Epirubicin—thyroid cancer	0.000161	0.000531	CcSEcCtD
Diltiazem—Dermatitis—Epirubicin—thyroid cancer	0.000161	0.000531	CcSEcCtD
Diltiazem—Headache—Epirubicin—thyroid cancer	0.00016	0.000528	CcSEcCtD
Diltiazem—Dizziness—Doxorubicin—thyroid cancer	0.000156	0.000515	CcSEcCtD
Diltiazem—Nausea—Epirubicin—thyroid cancer	0.000152	0.0005	CcSEcCtD
Diltiazem—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	0.000151	0.0081	CbGpPWpGaD
Diltiazem—CYP2C9—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000151	0.0081	CbGpPWpGaD
Diltiazem—Vomiting—Doxorubicin—thyroid cancer	0.00015	0.000495	CcSEcCtD
Diltiazem—Rash—Doxorubicin—thyroid cancer	0.000149	0.000491	CcSEcCtD
Diltiazem—Dermatitis—Doxorubicin—thyroid cancer	0.000149	0.000491	CcSEcCtD
Diltiazem—Headache—Doxorubicin—thyroid cancer	0.000148	0.000488	CcSEcCtD
Diltiazem—CYP2C19—Metapathway biotransformation—CHST14—thyroid cancer	0.000146	0.00783	CbGpPWpGaD
Diltiazem—CYP3A7—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000146	0.00779	CbGpPWpGaD
Diltiazem—ABCB1—HIF-1-alpha transcription factor network—CP—thyroid cancer	0.000144	0.00772	CbGpPWpGaD
Diltiazem—CACNA1S—NCAM signaling for neurite out-growth—NRAS—thyroid cancer	0.000144	0.00769	CbGpPWpGaD
Diltiazem—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—thyroid cancer	0.000144	0.00769	CbGpPWpGaD
Diltiazem—Nausea—Doxorubicin—thyroid cancer	0.00014	0.000463	CcSEcCtD
Diltiazem—CYP2D6—Metapathway biotransformation—CHST14—thyroid cancer	0.000135	0.00721	CbGpPWpGaD
Diltiazem—CYP2C9—Metapathway biotransformation—CHST14—thyroid cancer	0.000133	0.00714	CbGpPWpGaD
Diltiazem—CYP3A5—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.00013	0.00695	CbGpPWpGaD
Diltiazem—CACNA1S—NCAM signaling for neurite out-growth—KRAS—thyroid cancer	0.000124	0.00662	CbGpPWpGaD
Diltiazem—CACNA1S—Axon guidance—CDK1—thyroid cancer	0.000115	0.00615	CbGpPWpGaD
Diltiazem—ABCB1—HIF-1-alpha transcription factor network—EPO—thyroid cancer	0.000113	0.00606	CbGpPWpGaD
Diltiazem—CYP2C8—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000112	0.00602	CbGpPWpGaD
Diltiazem—CYP3A5—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000105	0.00563	CbGpPWpGaD
Diltiazem—CACNA1S—NCAM signaling for neurite out-growth—HRAS—thyroid cancer	0.000105	0.00563	CbGpPWpGaD
Diltiazem—CACNA1C—NCAM signaling for neurite out-growth—NRAS—thyroid cancer	0.000103	0.00549	CbGpPWpGaD
Diltiazem—CYP2C19—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.0001	0.00537	CbGpPWpGaD
Diltiazem—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	9.98e-05	0.00534	CbGpPWpGaD
Diltiazem—CACNA1S—Alzheimers Disease—TP53—thyroid cancer	9.75e-05	0.00522	CbGpPWpGaD
Diltiazem—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	9.74e-05	0.00521	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—MINPP1—thyroid cancer	9.28e-05	0.00497	CbGpPWpGaD
Diltiazem—CYP2D6—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	9.23e-05	0.00494	CbGpPWpGaD
Diltiazem—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	9.15e-05	0.0049	CbGpPWpGaD
Diltiazem—CYP2C8—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	9.11e-05	0.00488	CbGpPWpGaD
Diltiazem—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	9.1e-05	0.00487	CbGpPWpGaD
Diltiazem—CACNA1C—NCAM signaling for neurite out-growth—KRAS—thyroid cancer	8.82e-05	0.00472	CbGpPWpGaD
Diltiazem—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	8.8e-05	0.00471	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—CDK1—thyroid cancer	8.2e-05	0.00439	CbGpPWpGaD
Diltiazem—CACNA1C—Axon guidance—CDK1—thyroid cancer	8.2e-05	0.00439	CbGpPWpGaD
Diltiazem—CYP2C19—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	8.13e-05	0.00435	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—NDUFA13—thyroid cancer	7.89e-05	0.00422	CbGpPWpGaD
Diltiazem—CYP3A7—Biological oxidations—RXRA—thyroid cancer	7.73e-05	0.00414	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—RXRA—thyroid cancer	7.61e-05	0.00407	CbGpPWpGaD
Diltiazem—CACNA1C—NCAM signaling for neurite out-growth—HRAS—thyroid cancer	7.5e-05	0.00401	CbGpPWpGaD
Diltiazem—CYP2D6—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	7.48e-05	0.004	CbGpPWpGaD
Diltiazem—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	7.42e-05	0.00397	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—CHST14—thyroid cancer	7.41e-05	0.00397	CbGpPWpGaD
Diltiazem—ABCB1—HIF-1-alpha transcription factor network—TERT—thyroid cancer	7.05e-05	0.00377	CbGpPWpGaD
Diltiazem—CACNA1C—Alzheimers Disease—TP53—thyroid cancer	6.95e-05	0.00372	CbGpPWpGaD
Diltiazem—ABCB1—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	6.74e-05	0.00361	CbGpPWpGaD
Diltiazem—CYP2C8—Arachidonic acid metabolism—PTGS2—thyroid cancer	6.46e-05	0.00346	CbGpPWpGaD
Diltiazem—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	6.03e-05	0.00323	CbGpPWpGaD
Diltiazem—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	6e-05	0.00321	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—HPGD—thyroid cancer	5.98e-05	0.0032	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—CDK1—thyroid cancer	5.85e-05	0.00313	CbGpPWpGaD
Diltiazem—CYP2C19—Arachidonic acid metabolism—PTGS2—thyroid cancer	5.77e-05	0.00309	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—MINPP1—thyroid cancer	5.68e-05	0.00304	CbGpPWpGaD
Diltiazem—CYP3A5—Biological oxidations—RXRA—thyroid cancer	5.59e-05	0.00299	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—RXRA—thyroid cancer	5.43e-05	0.00291	CbGpPWpGaD
Diltiazem—CYP2C9—Arachidonic acid metabolism—PTGS2—thyroid cancer	5.26e-05	0.00281	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	5.15e-05	0.00275	CbGpPWpGaD
Diltiazem—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	4.89e-05	0.00262	CbGpPWpGaD
Diltiazem—CYP2C8—Biological oxidations—RXRA—thyroid cancer	4.84e-05	0.00259	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—NDUFA13—thyroid cancer	4.83e-05	0.00259	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—PPARG—thyroid cancer	4.8e-05	0.00257	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	4.59e-05	0.00246	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—CHST14—thyroid cancer	4.54e-05	0.00243	CbGpPWpGaD
Diltiazem—CYP2C19—Biological oxidations—RXRA—thyroid cancer	4.32e-05	0.00231	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	4.19e-05	0.00224	CbGpPWpGaD
Diltiazem—CACNA1S—Axon guidance—NRAS—thyroid cancer	4.12e-05	0.00221	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—MINPP1—thyroid cancer	4.11e-05	0.0022	CbGpPWpGaD
Diltiazem—CYP2D6—Biological oxidations—RXRA—thyroid cancer	3.97e-05	0.00213	CbGpPWpGaD
Diltiazem—CYP2C9—Biological oxidations—RXRA—thyroid cancer	3.94e-05	0.00211	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	3.88e-05	0.00208	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—HPGD—thyroid cancer	3.66e-05	0.00196	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—MINPP1—thyroid cancer	3.56e-05	0.0019	CbGpPWpGaD
Diltiazem—CACNA1S—Axon guidance—KRAS—thyroid cancer	3.55e-05	0.0019	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—NDUFA13—thyroid cancer	3.49e-05	0.00187	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—TPR—thyroid cancer	3.43e-05	0.00184	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—PPARG—thyroid cancer	3.43e-05	0.00183	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—PRKAR1A—thyroid cancer	3.38e-05	0.00181	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—CHST14—thyroid cancer	3.28e-05	0.00176	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—MINPP1—thyroid cancer	3.17e-05	0.0017	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—MINPP1—thyroid cancer	3.1e-05	0.00166	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—NDUFA13—thyroid cancer	3.02e-05	0.00162	CbGpPWpGaD
Diltiazem—CACNA1S—Axon guidance—HRAS—thyroid cancer	3.01e-05	0.00161	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—NRAS—thyroid cancer	2.94e-05	0.00157	CbGpPWpGaD
Diltiazem—CACNA1C—Axon guidance—NRAS—thyroid cancer	2.94e-05	0.00157	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—MINPP1—thyroid cancer	2.92e-05	0.00156	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—MINPP1—thyroid cancer	2.89e-05	0.00155	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—CHST14—thyroid cancer	2.84e-05	0.00152	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—NDUFA13—thyroid cancer	2.7e-05	0.00144	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—HPGD—thyroid cancer	2.65e-05	0.00142	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—NDUFA13—thyroid cancer	2.63e-05	0.00141	CbGpPWpGaD
Diltiazem—CYP3A4—Biological oxidations—RXRA—thyroid cancer	2.6e-05	0.00139	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—SLC5A5—thyroid cancer	2.57e-05	0.00138	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—CHST14—thyroid cancer	2.54e-05	0.00136	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—KRAS—thyroid cancer	2.53e-05	0.00135	CbGpPWpGaD
Diltiazem—CACNA1C—Axon guidance—KRAS—thyroid cancer	2.53e-05	0.00135	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—NDUFA13—thyroid cancer	2.48e-05	0.00133	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—CHST14—thyroid cancer	2.48e-05	0.00133	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—NDUFA13—thyroid cancer	2.46e-05	0.00132	CbGpPWpGaD
Diltiazem—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	2.45e-05	0.00131	CbGpPWpGaD
Diltiazem—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	2.45e-05	0.00131	CbGpPWpGaD
Diltiazem—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	2.41e-05	0.00129	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—CHST14—thyroid cancer	2.33e-05	0.00125	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—CHST14—thyroid cancer	2.31e-05	0.00124	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—HPGD—thyroid cancer	2.29e-05	0.00123	CbGpPWpGaD
Diltiazem—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	2.27e-05	0.00121	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—RXRA—thyroid cancer	2.16e-05	0.00116	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—HRAS—thyroid cancer	2.15e-05	0.00115	CbGpPWpGaD
Diltiazem—CACNA1C—Axon guidance—HRAS—thyroid cancer	2.15e-05	0.00115	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—TPR—thyroid cancer	2.1e-05	0.00113	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—NRAS—thyroid cancer	2.1e-05	0.00112	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—PRKAR1A—thyroid cancer	2.07e-05	0.00111	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—HPGD—thyroid cancer	2.05e-05	0.00109	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—HPGD—thyroid cancer	2e-05	0.00107	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	1.93e-05	0.00103	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—MINPP1—thyroid cancer	1.91e-05	0.00102	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—AKT1—thyroid cancer	1.9e-05	0.00102	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—HPGD—thyroid cancer	1.88e-05	0.00101	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—HPGD—thyroid cancer	1.87e-05	0.000998	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.86e-05	0.000995	CbGpPWpGaD
Diltiazem—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	1.83e-05	0.000981	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—KRAS—thyroid cancer	1.81e-05	0.000967	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	1.74e-05	0.000932	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	1.68e-05	0.000899	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.66e-05	0.000888	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—NDUFA13—thyroid cancer	1.62e-05	0.000869	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—SLC5A5—thyroid cancer	1.57e-05	0.000842	CbGpPWpGaD
Diltiazem—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.54e-05	0.000824	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—HRAS—thyroid cancer	1.53e-05	0.000822	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—CHST14—thyroid cancer	1.53e-05	0.000817	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—TPR—thyroid cancer	1.52e-05	0.000813	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.51e-05	0.00081	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	1.49e-05	0.0008	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—PPARG—thyroid cancer	1.36e-05	0.00073	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—AKT1—thyroid cancer	1.36e-05	0.000725	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—RXRA—thyroid cancer	1.32e-05	0.000708	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—TPR—thyroid cancer	1.32e-05	0.000705	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	1.29e-05	0.000693	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	1.29e-05	0.00069	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—HPGD—thyroid cancer	1.23e-05	0.000658	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—TPR—thyroid cancer	1.17e-05	0.000629	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.17e-05	0.000628	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	1.16e-05	0.000619	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—TPR—thyroid cancer	1.15e-05	0.000614	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	1.15e-05	0.000614	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—SLC5A5—thyroid cancer	1.14e-05	0.000609	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—PRKAR1A—thyroid cancer	1.13e-05	0.000604	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—TPR—thyroid cancer	1.08e-05	0.000578	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—PTGS2—thyroid cancer	1.07e-05	0.000574	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—TPR—thyroid cancer	1.07e-05	0.000573	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	1.06e-05	0.000569	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	1.05e-05	0.000564	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.05e-05	0.000561	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—SLC5A5—thyroid cancer	9.85e-06	0.000527	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	9.68e-06	0.000518	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—RXRA—thyroid cancer	9.56e-06	0.000512	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	9.55e-06	0.000511	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—PTEN—thyroid cancer	9.35e-06	0.000501	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	9.23e-06	0.000494	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—SLC5A5—thyroid cancer	8.79e-06	0.000471	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—SLC5A5—thyroid cancer	8.58e-06	0.000459	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—PPARG—thyroid cancer	8.35e-06	0.000447	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—RXRA—thyroid cancer	8.28e-06	0.000443	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	8.24e-06	0.000441	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—SLC5A5—thyroid cancer	8.09e-06	0.000433	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	8.05e-06	0.000431	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—SLC5A5—thyroid cancer	8.02e-06	0.000429	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	7.51e-06	0.000402	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—RXRA—thyroid cancer	7.39e-06	0.000396	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—RXRA—thyroid cancer	7.21e-06	0.000386	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	7.19e-06	0.000385	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—TPR—thyroid cancer	7.06e-06	0.000378	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	6.95e-06	0.000372	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—RXRA—thyroid cancer	6.8e-06	0.000364	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—RXRA—thyroid cancer	6.74e-06	0.000361	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—PTGS2—thyroid cancer	6.57e-06	0.000352	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	6.55e-06	0.000351	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—PPARG—thyroid cancer	6.03e-06	0.000323	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—PTEN—thyroid cancer	5.73e-06	0.000307	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—AKT1—thyroid cancer	5.39e-06	0.000289	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—SLC5A5—thyroid cancer	5.29e-06	0.000283	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—PPARG—thyroid cancer	5.23e-06	0.00028	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—PTGS2—thyroid cancer	4.75e-06	0.000254	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—PPARG—thyroid cancer	4.67e-06	0.00025	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—PPARG—thyroid cancer	4.55e-06	0.000244	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—RXRA—thyroid cancer	4.44e-06	0.000238	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—PPARG—thyroid cancer	4.29e-06	0.00023	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—PPARG—thyroid cancer	4.25e-06	0.000228	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—PTEN—thyroid cancer	4.14e-06	0.000222	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—PTGS2—thyroid cancer	4.11e-06	0.00022	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—PTGS2—thyroid cancer	3.67e-06	0.000196	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—PTEN—thyroid cancer	3.59e-06	0.000192	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—PTGS2—thyroid cancer	3.58e-06	0.000192	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—PTGS2—thyroid cancer	3.38e-06	0.000181	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—PTGS2—thyroid cancer	3.35e-06	0.000179	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—AKT1—thyroid cancer	3.3e-06	0.000177	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—PTEN—thyroid cancer	3.2e-06	0.000171	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—PTEN—thyroid cancer	3.12e-06	0.000167	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—PTEN—thyroid cancer	2.94e-06	0.000158	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—PTEN—thyroid cancer	2.92e-06	0.000156	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—PPARG—thyroid cancer	2.81e-06	0.00015	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—AKT1—thyroid cancer	2.39e-06	0.000128	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—PTGS2—thyroid cancer	2.21e-06	0.000118	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—AKT1—thyroid cancer	2.07e-06	0.000111	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—PTEN—thyroid cancer	1.92e-06	0.000103	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—AKT1—thyroid cancer	1.84e-06	9.87e-05	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—AKT1—thyroid cancer	1.8e-06	9.64e-05	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—AKT1—thyroid cancer	1.7e-06	9.08e-05	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—AKT1—thyroid cancer	1.68e-06	9e-05	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—AKT1—thyroid cancer	1.11e-06	5.94e-05	CbGpPWpGaD
